Date Filed | Type | Description |
02/12/2016 |
SC 13G/A
| SMALLCAP WORLD FUND INC reports a 0% stake in Synageva BioPharma Corp. |
06/24/2015 |
SC 13D/A
| BAKER BROS. ADVISORS LP reports a 0% stake in Synageva BioPharma Corp. |
06/23/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/23/2015 |
4
| BAKER FELIX (Former 10% owner and Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP |
06/23/2015 |
4
| Quinn Anthony (EVP, CMO, & Head of R&D) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP |
06/23/2015 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns:
| Disposed/sold 3,000 options to buy
@ $10.1, valued at
$30.3k
Disposed/sold 3,000 options to buy
@ $11.35, valued at
$34.1k
Disposed/sold 3,000 options to buy
@ $20.6, valued at
$61.8k
Disposed/sold 15,000 options to buy
@ $23, valued at
$345k
Disposed/sold 4,000 options to buy
@ $23.95, valued at
$95.8k
Disposed/sold 3,000 options to buy
@ $25, valued at
$75k
Disposed/sold 7,500 options to buy
@ $40.32, valued at
$302.4k
Disposed/sold 7,500 options to buy
@ $40.74, valued at
$305.6k
Disposed/sold 7,500 options to buy
@ $80.35, valued at
$602.6k
|
|
06/23/2015 |
4
| Patel Sanj K (President & CEO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns:
| Disposed/sold 286 shares
@ $0 Disposed/sold 1,031 shares
@ $0 Disposed/sold 72,000 shares
@ $0 Disposed/sold 22,512 options to buy
@ $1.7, valued at
$38.3k
Disposed/sold 136,052 options to buy
@ $23, valued at
$3.1M
Disposed/sold 128,000 options to buy
@ $40.32, valued at
$5.2M
Disposed/sold 148,000 options to buy
@ $40.74, valued at
$6M
Disposed/sold 120,000 options to buy
@ $80.35, valued at
$9.6M
|
|
06/23/2015 |
4
| Quart Barry D (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns:
| Disposed/sold 1,375 options to buy
@ $10.1, valued at
$13.9k
Disposed/sold 1,500 options to buy
@ $11.35, valued at
$17k
Disposed/sold 1,375 options to buy
@ $20.6, valued at
$28.3k
Disposed/sold 8,375 options to buy
@ $23, valued at
$192.6k
Disposed/sold 1,000 options to buy
@ $23.95, valued at
$24k
Disposed/sold 5,001 options to buy
@ $40.32, valued at
$201.6k
Disposed/sold 3,750 options to buy
@ $40.74, valued at
$152.8k
Disposed/sold 7,500 options to buy
@ $80.35, valued at
$602.6k
|
|
06/23/2015 |
4
| TISCH THOMAS J (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP |
06/23/2015 |
4
| Bazemore Robert B (COO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns:
| Disposed/sold 35,000 shares
@ $0 Disposed/sold 50,000 options to buy
@ $63.11, valued at
$3.2M
|
|
06/23/2015 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP |
06/23/2015 |
4
| Heberlig Chris (SVP, Finance & Business Ops.) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP |
06/23/2015 |
4
| Williams Glen (SVP, Technical Operations) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP |
06/23/2015 |
4
| Malley Thomas (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP |
06/23/2015 |
4
| WIRTH PETER (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP |
06/23/2015 |
8-K
| Form 8-K - Current report |
06/22/2015 |
4
| BAKER JULIAN (10% Owner) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP |
06/22/2015 |
4
| BAKER FELIX (10% Owner) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns:
| Disposed of 206,800 shares
@ $0 Acquired 19,318 shares
@ $0 Disposed of 165,213 shares
@ $0 Acquired 12,500 shares
@ $0 Disposed of 55,479 shares
@ $0 Acquired 5,543 shares
@ $0 Disposed of 1,068,128 shares
@ $0 Acquired 40,449 shares
@ $0 Disposed of 100,490 shares
@ $0 Acquired 497 shares
@ $0 Disposed of 211,614 shares
@ $0 |
|
06/22/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
06/22/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/22/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
06/12/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/12/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
06/11/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/11/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
06/10/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/10/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
06/10/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
06/10/2015 |
SC 13G/A
| Capital Research Global Investors reports a 4.7% stake in Synageva BioPharma Corp. |
06/10/2015 |
SC 13G/A
| FMR LLC reports a 2.2% stake in SYNAGEVA BIOPHARMA CORP |
06/09/2015 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP |
06/09/2015 |
4
| Heberlig Chris (SVP, Finance & Business Ops.) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP |
06/09/2015 |
4
| Patel Sanj K (President & CEO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns:
| Granted 72,000 shares
@ $0 |
|
06/09/2015 |
4
| Bazemore Robert B (COO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns:
| Granted 5,000 shares
@ $0 |
|
|